Application Notes & Case Studies

  1. Development Of A Non-Standard Protein Therapeutic 9/9/2025

    Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.

  2. Phenotypic Characterization Of Bleomycin-Induced Pulmonary Fibrosis Mod 9/8/2025

    To gain deeper biological insight, lung injury in this model has been further characterized through cellular phenotyping, gene expression analysis, and cytokine profiling.

  3. Decoding The Conformational Plasticity Of Ternary Complexes For Protacs' Differential Activity 9/8/2025

    Leverage our insights into PROTAC ternary complex plasticity and stability to accelerate the design of next-generation therapeutics.

  4. Scalable Production Of High-Purity Nanobodies Using Yeast Expression System 9/8/2025

    Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.

  5. Streptozotocin-Induced Diabetic Peripheral Neuropathic Pain Model 9/8/2025

    Emerging research highlights that insulin deficiency drives sensory neuropathy, and early insulin therapy may help prevent or alleviate chronic diabetic neuropathic pain.

  6. Driving Seamless Tech Transfer Of Multiple Projects Within A Short Timeline 9/4/2025

    Uncover how we were able to provide seamless technology transfers and uninterrupted production to deliver critical therapies efficiently and reliably to patients.

  7. Analytical Tools To Address The Development Of GLP-1 Receptor Agonists 9/2/2025

    GLP-1 receptor agonists are revolutionizing therapeutics beyond diabetes. Explore analytical innovations that ensure safety and efficacy as these peptides expand into multiple treatments.

  8. Overcoming Excipient Risks And Challenges For Parenteral Formulations 8/27/2025

    Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.

  9. Validation Provider Shortens The Path To Equipment Qualification 8/19/2025

    Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.

  10. Generation Of A Contamination Control Strategy 8/16/2025

    An unaddressed compliance issue related to contamination control can pose a significant risk to a life sciences organization. This case study details a company's journey toward sustainable compliance.